Pharmaceutical Foul Play: Novo Nordisk Sues Eli Lilly Over Deceptive Ads The pharmaceutical industry has long grappled with questions of ethics and honesty in advertising.
The latest case in point is a lawsuit filed by Novo Nordisk against Eli Lilly, alleging that the latter's marketing campaigns for its weight loss and diabetes drugs are deliberately misleading consumers.
Novo's complaint centers on the use of outdated clinical data by Eli Lilly to promote its products Zepbound and Mounjaro.